Vytorin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.
Condition:   Hypercholesterolemia Interventions:   Drug: Inclisiran;   Drug: Ezetimibe;   Drug: Matching Placebo for Inclisiran;   Drug: Matching Placebo for Ezetimibe Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2023 Category: Research Source Type: clinical trials